Clinicopathological Factors and Nomogram Construction for Lymph Node Metastasis in Locally Advanced Gastric Cancer

被引:0
作者
Yu, Zhiyuan [1 ,2 ,3 ]
Liu, Haopeng [4 ]
Li, Rui [1 ,2 ,3 ]
Hu, Liai [3 ]
Xiao, Chun [5 ]
Gao, Yunhe [2 ]
Li, Peiyu [1 ,3 ]
Liang, Wenquan [2 ]
Zhou, Sixin [2 ]
Zhao, Xudong [2 ]
机构
[1] Med Sch Chinese PLA, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Gen Surg, Fuxing Rd 28, Beijing 100853, Peoples R China
[3] Nankai Univ, Sch Med, Tianjin, Peoples R China
[4] Zhangqiu Dist Peoples Hosp, Dept Hepatobiliary Surg, Jinan, Shandong, Peoples R China
[5] PLA Rocket Force Characterist Med Ctr, Dept Gen Surg, Beijing, Peoples R China
关键词
locally advanced gastric cancer; lymph node metastasis; clinicopathological factors; nomogram; RISK-FACTORS; STAGE;
D O I
10.2147/CMAR.S487247
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The research on lymph node metastasis (LNM) in locally advanced gastric cancer (LAGC) infiltrating the subserous tissue and serous membrane (T3-4a) is significantly inadequate. This study aims to explore the clinicopathological factors related to LNM in stages T3 and T4a LAGC, while also developing predictive nomograms. Methods: After systematic searching and rigorous screening, 1995 T3 and 1244 T4a LAGC cases who underwent surgery without neoadjuvant or perioperative chemotherapy were selected. The risk factors associated with LNM were identified using both univariate and multivariate logistic regression analyses. Subsequently, the independent variables identified through the multivariate analyses were utilized to construct a nomogram. Results: The incidence of LNM in T3 and T4a LAGC was 77.1% (1539/1995) and 83.8% (1043/1244), respectively. The following factors were found to be independently associated with LNM in T3 LAGC: preoperative serum albumin < 41g/L (P=0.007), gastrointestinal obstruction (P< 0.001), tumor location (P=0.040), tumor size > 4cm (P=0.002), mixed (P=0.001) and undifferentiated histological types (P=0.002), presence of lymphovascular invasion (LVI) (P< 0.001) and nerve invasion (P< 0.001). Additionally, in T4a LAGC cases, serum albumin < 39g/L (P=0.004), tumor size > 6cm (P=0.020), mixed (P< 0.001) and undifferentiated histological types (P< 0.001), presence of gastrointestinal hemorrhage (P=0.016), neuroendocrine differentiation (P=0.024), and LVI (P< 0.001) independently influenced the occurrence of LNM. Conclusion: This study identified the risk factors associated with LNM in T3-4a LAGC cases and constructed nomograms, thereby providing valuable guidance for formulating and implementing a multidisciplinary perioperative treatment program.
引用
收藏
页码:1475 / 1489
页数:15
相关论文
共 31 条
[1]   Gastric Cancer, Version 2.2022 [J].
Ajani, Jaffer A. ;
D'Amico, Thomas A. ;
Bentrem, David J. ;
Chao, Joseph ;
Cooke, David ;
Corvera, Carlos ;
Das, Prajnan ;
Enzinger, Peter C. ;
Enzler, Thomas ;
Fanta, Paul ;
Farjah, Farhood ;
Gerdes, Hans ;
Gibson, Michael K. ;
Hochwald, Steven ;
Hofstetter, Wayne L. ;
Ilson, David H. ;
Keswani, Rajesh N. ;
Kim, Sunnie ;
Kleinberg, Lawrence R. ;
Klempner, Samuel J. ;
Lacy, Jill ;
Ly, Quan P. ;
Matkowskyj, Kristina A. ;
McNamara, Michael ;
Mulcahy, Mary F. ;
Outlaw, Darryl ;
Park, Haeseong ;
Perry, Kyle A. ;
Pimiento, Jose ;
Poultsides, George A. ;
Reznik, Scott ;
Roses, Robert E. ;
Strong, Vivian E. ;
Su, Stacey ;
Wang, Hanlin L. ;
Wiesner, Georgia ;
Willett, Christopher G. ;
Yakoub, Danny ;
Yoon, Harry ;
McMillian, Nicole ;
Pluchino, Lenora A. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (02) :167-192
[2]   Review article: the investigation and management of gastric neuroendocrine tumours [J].
Basuroy, R. ;
Srirajaskanthan, R. ;
Prachalias, A. ;
Quaglia, A. ;
Ramage, J. K. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) :1071-1084
[3]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]
[4]   Association of the Collagen Signature in the Tumor Microenvironment With Lymph Node Metastasis in Early Gastric Cancer [J].
Chen, Dexin ;
Chen, Gang ;
Jiang, Wei ;
Fu, Meiting ;
Liu, Wenju ;
Sui, Jian ;
Xu, Shuoyu ;
Liu, Zhangyuanzhu ;
Zheng, Xiaoling ;
Chi, Liangjie ;
Lin, Dajia ;
Li, Kai ;
Chen, Weisheng ;
Zuo, Ning ;
Lu, Jianping ;
Chen, Jianxin ;
Li, Guoxin ;
Zhuo, Shuangmu ;
Yan, Jun .
JAMA SURGERY, 2019, 154 (03)
[5]   Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study [J].
Dong, D. ;
Fang, M. -J. ;
Tang, L. ;
Shan, X. -H. ;
Gao, J. -B. ;
Giganti, F. ;
Wang, R. -P. ;
Chen, X. ;
Wang, X. -X. ;
Palumbo, D. ;
Fu, J. ;
Li, W. -C. ;
Li, J. ;
Zhong, L. -Z. ;
De Cobelli, F. ;
Ji, J. -F. ;
Liu, Z. -Y. ;
Tian, J. .
ANNALS OF ONCOLOGY, 2020, 31 (07) :912-920
[6]   Neuroendocrine differentiation in gastric adenocarcinomas;: Correlation with tumor stage and expression of VEGF and p53 [J].
Eren, F ;
Çelikel, C ;
Güllüoglu, B .
PATHOLOGY & ONCOLOGY RESEARCH, 2004, 10 (01) :47-51
[7]   Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis [J].
He, Xingkang ;
Wu, Wenrui ;
Lin, Zhenghua ;
Ding, Yue ;
Si, Jianmin ;
Sun, Lei-min .
GASTRIC CANCER, 2018, 21 (03) :391-400
[8]   The 8th edition American Joint Committee on gastric cancer pathological staging classification performs well in a population with high proportion of locally advanced disease [J].
Huang, Shu-Fang ;
Chien, Ti-Hsuan ;
Fang, Wen-Liang ;
Wang, Frank ;
Tsai, Chun-Yi ;
Hsu, Jun-Te ;
Yeh, Chun-Nan ;
Chen, Tse-Ching ;
Wu, Ren-Chin ;
Chiu, Cheng-Tang ;
Yeh, Ta-Sen .
EJSO, 2018, 44 (10) :1634-1639
[9]   Japanese gastric cancer treatment guidelines 2018 (5th edition) [J].
Japanese Gastric Cancer Association .
GASTRIC CANCER, 2021, 24 (01) :1-21
[10]   PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer [J].
Kang, Yoon-Koo ;
Yook, Jeong Hwan ;
Park, Young-Kyu ;
Lee, Jong Seok ;
Kim, Young-Woo ;
Kim, Jin Young ;
Ryu, Min-Hee ;
Rha, Sun Young ;
Chung, Ik Joo ;
Kim, In-Ho ;
Oh, Sang Cheul ;
Park, Young Soo ;
Son, Taeil ;
Jung, Mi Ran ;
Heo, Mi Hwa ;
Kim, Hark Kyun ;
Park, ChoHyun ;
Yoo, Chang Hak ;
Choi, Jin-Hyuk ;
Zang, Dae Young ;
Jang, You Jin ;
Sul, Ji Young ;
Kim, Jong Gwang ;
Kim, Beom Su ;
Beom, Seung-Hoon ;
Cho, Sang Hee ;
Ryu, Seung Wan ;
Kook, Myeong-Cherl ;
Ryoo, Baek-Yeol ;
Kim, Hyun Ki ;
Yoo, Moon-Won ;
Lee, Nam Su ;
Lee, Sang Ho ;
Kim, Gyunji ;
Lee, YeonJu ;
Lee, Jee Hyun ;
Noh, Sung Hoon .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (26) :2903-+